Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Biosimilars: SOP for DO Cascade Settings in Bioreactor Operations – V 2.0

Posted on By


Biosimilars: SOP for DO Cascade Settings in Bioreactor Operations – V 2.0


Standard Operating Procedure for DO Cascade Settings in Bioreactor Operations for Biosimilars

Department Biosimilars
SOP No. SOP/BS/077/2025
Supersedes SOP/BS/077/2022
Page No. Page 1 of 12
Issue Date 04/05/2025
Effective Date 06/05/2025
Review Date 04/05/2026

1. Purpose

To define the procedure for configuring, verifying, and managing Dissolved Oxygen (DO) cascade settings in bioreactor operations to ensure optimal cell growth conditions during biosimilar manufacturing.

2. Scope

This SOP is applicable to all bioreactor systems used for mammalian cell culture in upstream processes for biosimilar production where automated oxygen control via cascade logic is implemented.

3. Responsibilities

  • Bioreactor Operators: Set and monitor DO cascade parameters during fermentation runs.
  • Automation/Engineering Team: Maintain PLC control logic and validate DO cascade software configurations.
  • QA Department: Review and approve DO cascade setting records and change controls.

4. Accountability

The Head of Upstream Manufacturing is accountable for ensuring correct implementation of DO cascade systems as per validated process requirements.

5. Procedure

5.1 Sensor Calibration

  1. Calibrate DO sensors before every production batch using two-point calibration:
    • 0% (using nitrogen-purged solution)
    • 100% (using air-saturated water)
  2. Document calibration results in the DO Sensor Calibration Log (Annexure-1).

5.2 Cascade Parameter Configuration

  1. Access the control system HMI or SCADA interface and navigate to the DO cascade menu.
  2. Set the DO setpoint to 30% or as per batch record.
  3. Configure cascade steps in the following sequence:
    1. Step 1: Increase agitation from 100 to 300 RPM.
    2. Step 2: Increase air flow rate from 0.1 to 1.0 vvm.
    3. Step 3: Introduce pure oxygen blending if DO remains below setpoint.
  4. Enable PID control loop and confirm tuning parameters are as validated.

5.3 Cascade Verification

  1. Simulate low DO by manually increasing cell density in test mode or using nitrogen sparging.
  2. Verify automatic activation of each cascade step in correct order.
  3. Ensure system returns to baseline once DO reaches setpoint.
  4. Record cascade test results in Annexure-2.

5.4 Monitoring During Batch Run

  1. Monitor DO values continuously during the culture phase.
  2. Ensure cascade is active and system is responding to DO fluctuations.
  3. Log agitation, airflow, and oxygen blending trends every 4 hours (Annexure-3).

5.5 Deviation Handling

  1. If DO fails to recover despite cascade, escalate to engineering and shift to manual control.
  2. Log deviation and corrective actions in deviation report.

6. Abbreviations

  • DO: Dissolved Oxygen
  • HMI: Human Machine Interface
  • SCADA: Supervisory Control and Data Acquisition
  • vvm: Volume of air per volume of medium per minute

7. Documents

  1. DO Sensor Calibration Log – Annexure-1
  2. DO Cascade Verification Checklist – Annexure-2
  3. DO Cascade Monitoring Log – Annexure-3

8. References

  • ICH Q8 – Pharmaceutical Development
  • WHO TRS 1010 – Bioprocess Equipment Control

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: DO Sensor Calibration Log

Date Bioreactor ID 0% Calibration (mV) 100% Calibration (mV) Calibrated By
04/05/2025 BR-12 12.6 198.4 Rajesh Kumar

Annexure-2: DO Cascade Verification Checklist

Step Parameter Status Tested By Date
1 Agitation Increase Pass Sunita Reddy 04/05/2025
2 Air Flow Increase Pass Sunita Reddy 04/05/2025
3 Oxygen Blending Pass Sunita Reddy 04/05/2025

Annexure-3: DO Cascade Monitoring Log

Date Time DO (%) Agitation (RPM) Air Flow (vvm) O2 Blending (%) Operator
04/05/2025 12:00 30.1 220 0.6 5 Ajay Verma

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
04/05/2025 2.0 Updated control logic, cascade sequence, and annexures Process Automation Enhancement
See also  Biosimilars: SOP for Equipment Logbook Maintenance - V 2.0
Biosimilars V 2.0 Tags:biosimilar manufacturing SOP, biosimilar process validation SOP, biosimilar quality control procedure, cell line development SOP biosimilars, chromatography SOP biosimilars, cleaning validation SOP for biosimilar equipment, cleanroom SOP for biologics manufacturing, deviation handling SOP in bioprocess, downstream processing SOP, environmental monitoring SOP biosimilars, GMP SOP for biosimilars, host cell protein removal SOP, inline UV monitoring SOP biosimilars, media preparation SOP for biosimilars, protein purification SOP, purification skid calibration SOP, SOP for bioreactor inoculation biosimilars, SOP for biosimilar cell banking, SOP for cell culture in biosimilar production, SOP for chromatography column packing, SOP for ELISA-based clone screening, SOP for endotoxin testing in biologics, SOP for filter sterilization in downstream processing, SOP for glycosylation analysis in biosimilars, SOP for master cell bank, SOP for protein A chromatography steps, SOP for resin qualification in biosimilar purification, SOP for viral clearance in biosimilar production, SOP for working cell bank, upstream processing SOP biosimilars

Post navigation

Previous Post: SOP for Ensuring Data Integrity in Quality Control Records
Next Post: Analytical Method Development: Residual Solvent Estimation by HPLC – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version